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Interferon Regulatory Factor 6 Promotes
Differentiation of the Periderm by Activating
Expression of Grainyhead-Like 3
Gabriel de la Garza1,10, Jack Robert Schleiffarth1,10, Martine Dunnwald2,3, Anuj Mankad4, Jason L.
Weirather2, Gregory Bonde4, Stephen Butcher5, Tamer A. Mansour6, Youssef A. Kousa7, Cindy F. Fukazawa8,
Douglas W. Houston2,5, J. Robert Manak2,3,5, Brian C. Schutte6,7,9, Daniel S. Wagner8 and Robert A. Cornell2,4
IFN regulatory factor 6 (IRF6) is a transcription factor that, in mammals, is required for the differentiation of skin,
breast epithelium, and oral epithelium. However, the transcriptional targets that mediate these effects are
currently unknown. In zebrafish and frog embryos, Irf6 is necessary for differentiation of the embryonic
superficial epithelium, or periderm. Here we use microarrays to identify genes that are expressed in the
zebrafish periderm and whose expression is inhibited by a dominant-negative variant of Irf6 (dnIrf6). These
methods identify Grainyhead-like 3 (Grhl3), an ancient regulator of the epidermal permeability barrier, as acting
downstream of Irf6. In human keratinocytes, IRF6 binds conserved elements near the GRHL3 promoter. We
show that one of these elements has enhancer activity in human keratinocytes and zebrafish periderm,
suggesting that Irf6 directly stimulates Grhl3 expression in these tissues. Simultaneous inhibition of grhl1 and
grhl3 disrupts periderm differentiation in zebrafish, and, intriguingly, forced grhl3 expression restores periderm
markers in both zebrafish injected with dnIrf6 and frog embryos depleted of Irf6. Finally, in Irf6-deficient mouse
embryos, Grhl3 expression in the periderm and oral epithelium is virtually absent. These results indicate that
Grhl3 is a key effector of Irf6 in periderm differentiation.
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INTRODUCTION
IFN regulatory factor 6 (IRF6) drives the differentiation of
epithelia with barrier function via unknown mechanisms. In
mice deficient for Irf6, epidermal keratinocytes fail to
differentiate terminally, resulting in the absence of an
epidermal permeability barrier (Ingraham et al., 2006;
Richardson et al., 2006; Biggs et al., 2012). Moreover, the
superficial layer of the oral epithelium, the oral periderm, is
missing in Irf6 mutants, resulting in adhesion between the
palatal shelves and the tongue (Richardson et al., 2009).
Mutations in IRF6 cause two syndromic forms of cleft lip and
palate (CL/P): the Van der Woude and the Popliteal Pterygium
syndromes (Kondo et al., 2002). They are also associated with
nonsyndromic CL/P (Zucchero et al., 2004; Koillinen et al.,
2005; Srichomthong et al., 2005; Pegelow et al., 2008;
Desmyter et al., 2010). In patients with such mutations,
abnormal differentiation of the epidermis or oral periderm
may contribute to CL/P pathogenesis. In addition, IRF6
appears to be necessary for normal wound healing (Jones
et al., 2010), it promotes differentiation of the breast
epithelium (Bailey et al., 2008), and it functions as a tumor
suppressor in squamous cell carcinoma (Botti et al., 2011). A
recent study identified hundreds of genomic loci that are
bound by IRF6 in human keratinocytes (Botti et al., 2011), but
it is unclear which of these apparent transcriptional targets
effect epithelial differentiation.
The aim of this study was to characterize the position of
Irf6 within the gene regulatory network that controls
differentiation of the periderm in zebrafish, as many aspects
of mammalian skin biology are conserved in fish (Li et al.,
2011). The periderm is a simple squamous epithelium that is
the most superficial layer of an embryo and forms the first
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permeability barrier to dehydration in mouse embryos
(M’Boneko and Merker, 1988). In both fish and amphibian
embryos, the periderm forms in early gastrula stage and is
necessary for structural integrity of the embryo during this
period (Fukazawa et al., 2010). We previously showed that
the periderm is disrupted in both zebrafish embryos injected
with RNA encoding a dominant-negative variant Irf6 (dnIrf6)
and in frog embryos depleted of maternal Irf6: the expression
of various periderm markers is lost, and the periderm itself
ruptures (Sabel et al., 2009). Here, through microarray
analysis, in vivo reporter studies, and epistasis experiments,
we identify the gene encoding Grainyhead-like 3 (Grhl3), an
ancient mediator of epithelial integrity, as a direct effector of
Irf6 in periderm differentiation.
RESULTS
Potential regulators of periderm differentiation
We assessed the gene expression profile of isolated zebrafish
periderm cells using the Tg(krt4:gfp) transgenic zebrafish line,
in which green fluorescent protein (GFP) is robustly
expressed in simple epithelia of the embryo (Gong et al.,
2002). Through cell sorting and microarray analyses, we
identified a subset of genes expressed in GFPþ cells at levels
at least threefold higher than in GFP cells (Figure 1a and b).
This ‘‘periderm-enriched profile’’ (Supplementary Table S1
online) is significantly enriched for genes with ontology terms
typical of those present in other epithelia (See Materials and
Methods). The 70 transcription factor–encoding genes repre-
sented in this profile (Supplementary Table S1 online)
potentially participate in the periderm gene regulatory
network, either upstream or downstream of Irf6.
To learn where Irf6 fits into this network, we created a
profile of genes whose expression is altered in the presence of
dnIrf6. We did not use antisense morpholino oligonucleo-
tides (MO), the standard tools for reducing gene expression in
zebrafish embryos, because they are commonly ineffective
against maternally encoded transcripts (Draper et al., 2001),
and this proved to be the case for Irf6 (Supplementary Figure
S1 online). Instead, we modified the dnIrf6 generated for our
earlier study (Sabel et al., 2009) by fusing the Irf6 DNA-
binding domain to the Engrailed repressor domain. We
injected embryos with an RNA encoding either dnIrf6 or b-
galactosidase (i.e., lacZ RNA), harvested RNA at 6 hours post
fertilization (h.p.f.; such embryos rupture by 7 h.p.f.), and
probed microarrays as described above. We identified a
subset of genes that are expressed at significantly lower levels
in dnIrf6-injected embryos than in lacZ-injected embryos and
refer to this as the ‘‘dnIrf6-inhibited profile’’ (Figure 1c and d,
Supplementary Table S2 online); it contains many genes that
encode adhesion molecules, consistent with rupture of the
periderm in dnIrf6-injected embryos.
Of the genes present in both the periderm-enriched and
dnIrf6-inhibited profiles (Figure 1e; Supplementary Table S3
online), 10 are classified by the gene ontology term
‘‘transcription factor activity’’ and therefore may participate
in the periderm gene regulatory network downstream of
Irf6 (Table 1). Among these, grhl1 and klf2b are of special
interest because homologs of these genes, Grhl3 and Klf4,
respectively, are required to generate the epidermal perme-
ability barrier in mice (Segre et al., 1999; Ting et al., 2005).
However, probes for the zebrafish orthologs of neither Grhl3
nor Klf4 are present in the microarray we deployed. Therefore,
we assessed the expression of these genes, and that of several
others common to the two profiles, by in situ hybridization.
We found that all are indeed downregulated in dnIrf6-injected
embryos versus control-injected embryos (Figure 1f–w), and
that epcam, which is present only in the former profile, is
indeed expressed in dnIrf6-injected embryos (Figure 1x
and y). Moreover, we found that coinjecting an RNA encoding
full-length Irf6 partially reversed the effects of dnIrf6 (Figure
1z), supporting the idea that those effects result from
interference with Irf6 and/or closely related proteins. Genes
in the periderm-enriched profile whose expression was
significantly elevated in the presence of dnIrf6 are candidates
for repression by Irf6, although most are likely to be affected
indirectly because dnIrf6 is a constitutive repressor. Interest-
ingly, p63, which regulates epidermal differentiation in mice
and zebrafish and directly regulates Irf6 expression, ranks
among these genes (Bakkers et al., 2002; Lee and Kimelman,
2002; Moretti et al., 2010; Thomason et al., 2010). In
summary, profiling experiments revealed several genes that
are likely to be members of the periderm gene regulatory
network that act downstream of Irf6.
Irf6 activates epithelial enhancers adjacent to Grhl3
We next sought to test the possibility that Irf6 directly
activates grhl3 expression in the periderm. In a recent
chromatin immunoprecipitation experiment conducted in
human keratinocytes, IRF6 was found to be bound at two
locations near the first exon of GRHL3—about 2 kb upstream
and about 3 kb downstream (intronic; Figure 2a; Botti et al.,
2011). Both peaks are within chromatin elements that are
conserved among mammals and are sites of DNAse
hypersensitivity in human keratinocytes (ENCODE project).
Thus, these elements may have cis-regulatory function. In
addition, microarray analysis revealed that GRHL3 expres-
sion is reduced in cells depleted of IRF6, suggesting that IRF6
directly activates GRHL3 expression in keratinocytes (Botti
et al., 2011). To test this possibility, we amplified the
conserved elements containing these peaks and cloned them
into a firefly luciferase reporter vector containing a minimal
promoter (Figure 2a). In a human keratinocyte cell line
transfected with the construct containing the intron-1
element, but not in one transfected with the construct
containing the upstream element, luciferase levels were
significantly higher than in a line transfected with a control
construct (Figure 2b). Although neither IRF6-bound element
is detectably conserved in zebrafish, the functions of
mammalian enhancer elements without detectable counter-
parts in zebrafish are nonetheless often conserved in
zebrafish embryos (Fisher et al., 2006; McGaughey et al.,
2008, 2009). We thus cloned the elements into a reporter
vector that contains a minimal promoter and the gene
encoding GFP (Figure 2a; vector described in Fisher et al.
(2006)) and injected these constructs into wild-type zebrafish
embryos. About 20% of the embryos injected with
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Figure 1. Microarray analysis of zebrafish periderm. (a, c) Schematic representation of methods used to create the periderm-enriched (a) and the dominant-
negative variant of IFN regulatory factor 6 (dnIrf6)-inhibited (c) profile. (b, d) Pie charts showing genes whose expression is (b) 3 higher in FACS-sorted green
fluorescent protein (GFP)-positive versus GFP-negative cells (c) or significantly reduced (41.7-fold) in dnIrf6-injected compared with lacZ-injected embryos (d).
(e) Venn diagram portraying the overlap of sets in b and d. (f–y) Animal-pole view of midgastrula-stage embryos, uninjected or injected with dnIrf6, and
processed to reveal expression of the indicated gene. All are expressed in periderm and all, except y (epcam), are strongly reduced in dnIrf6-injected embryos.
Bar¼100 mM (f). (z) Quantitative reverse transcription PCR for genes whose expression is reduced by dnIrf6 and significantly elevated (with respect to dnIrf6
alone) by coinjection with Irf6 (Po0.05) (asterisks). cDNA, complementary DNA; h.p.f., hours post fertilization.
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hGRHL3_peak2:gfp exhibited GFP expression in contiguous
patches of periderm cells (recognizable because of their
characteristic polygonal morphology), starting at high stage
and continuing to at least 72h.p.f. (shown on the yolk at
48h.p.f., Figure 2c; numbers of injected embryos for reporter
experiments are presented in Materials and Methods). Embryos
injected with hGRHL3_peak1:gfp or the vector lacking either
element did not exhibit these patches. These studies support
the idea that Irf6 directly activates grhl3 expression in both
human keratinocytes and zebrafish periderm.
As an alternative approach for identifying Irf6-dependent
enhancers, we searched mammalian and zebrafish genomes
for the presence of conserved, noncoding elements that
possess the consensus Irf6 response element (Little et al.,
2009). Although we did not detect any that are conserved
between mammals and zebrafish, we found one (within
intron 15 of GRHL3) that is conserved among mammals
(Figure 2d). Although IRF6 binding of this site was not
reported in keratinocytes (Botti et al., 2011), it could
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Figure 2. Enhancer activity of DNA elements near Grainyhead-like 3 (GRHL3). (a) Positions of Irf6 binding peaks in human keratinocytes from a ChIP-SEQ
experiment (Botti et al., 2011), and construction of luciferase and green fluorescent protein (GFP) reporter vectors with these peaks. (b) Results of luciferase
reporter assay. (c, f–h) Transient (c, f, g) and stable (h) transgenic zebrafish embryos of the indicated constructs with GFP expression in the periderm. (d)
Schematic representation of a conserved element within GRHL3 intron-15 (gray box), which contains a conserved Irf6 response element (IRF6-RE), underlined.
Position-weighted matrix for IRF6-RE defined in vitro (Little et al., 2009) and in vivo (Botti et al., 2011). (e) Electromobility shift assay with human IRF6DBD and
a labeled probe that matches 25 base pairs of the hGrhl3 intron 15 that encompass the putative Irf6RE. Bars¼ (c) 100mm and (f) 200mm. eGFP, enhanced green
fluorescent protein; h.p.f., hours post fertilization.
Table 1. Genes encoding transcription factors in both
the periderm-enriched and dnIrf6-inhbited profiles
Gene ID Gene name
ENSDART00000082425 GATA-binding protein 2a
ENSDART00000021159 LIM homeobox 1b
ENSDART00000080693 LIM homeobox 5
ENSDART00000060861 Forkhead box P2
ENSDART00000025153 GATA-binding protein 3
ENSDART00000052521 Nuclear factor of activated T-cells,
cytoplasmic, calcineurin-dependent 1
ENSDART00000052570 Paired-like homeodomain transcription
factor 2
ENSDART00000017456 Ventral expressed homeobox
ENSDART00000087454 Grainyhead-like 1
ENSDART00000059188 Klf2b, Kruppel-like factor 2b
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potentially occur in other cell types including those of the
periderm. Indeed, we found that an oligonucleotide that
matches the GRHL3 intron sequence encompassing the
apparent Irf6 binding site competes with a control probe for
the binding of Irf6DBD in vitro, and that a version of the
oligo in which this site has been altered lacks this ability
(Figure 2e). To test the potential enhancer activity of the
conserved element within GRHL3 intron-15, we amplified it
(972 bp) from the murine genome and cloned it into the GFP
reporter vector (creating mGrhl3intron15:gfp). In both tran-
sient and stable transgenic embryos harboring this construct,
GFP is expressed in the periderm (Figure 2f and h). In
addition, we generated a construct in which six bases within
the Irf6RE are mutated (as in the in vitro binding experiment
described above), creating intron15DIrf6RE:gfp (Figure 2g).
In embryos injected with this construct, GFP expression
was rarely detected in periderm cells and was completely
extinguished by 48 h.p.f. (Figure 2g). In summary, a con-
served element within intron-15 of mammalian Grhl3 has
periderm enhancer activity that depends on the presence of a
consensus Irf6 binding site.
Inhibition of grhl1 and grhl3 disrupts periderm development
Three members of the Grhl family are expressed in the
zebrafish periderm (Janicke et al., 2010). Because Grhl family
members share a core DNA consensus binding site (Ting
et al., 2005; Wilanowski et al., 2008; Rifat et al., 2010;
Boglev et al., 2011), we reasoned that overexpressing the
DNA-binding domain (DBD) of any is likely to displace them
all from DNA. We thus injected zebrafish embryos with an
RNA encoding the Xenopus Xgrhl1 DBD (dnXgrhl1). This
resulted in stalled epiboly and embryonic rupture, much as in
dnIrf6-injected embryos (not shown, 29 of 30 injected
embryos; Tao et al., 2005). We found that mosaic injection
of dnXgrhl1 blocked krt4 expression in a cell autonomous
manner (Figure 3a and b). To determine which family
members are essential for development of the zebrafish
periderm, we injected MOs known to target the grhl1 start
codon (Janicke et al., 2010) or to block the splicing of grhl3
(confirmed in Supplementary Figure S2 online). Epiboly was
not affected when either was injected alone, but when both
were injected simultaneously the expression of krt4, capn9,
and ovol1b was significantly reduced, epiboly was delayed,
and the embryos ruptured analysis at the animal pole (Figure
3c–j). Reverse transcriptase PCR (i.e., qRT-PCR) analysis
confirmed that the combination of MOs targeting grhl1 and
grhl3 reduced expression of krt4 (Supplementary Figure S2
online). Thus, Grhl1 and Grhl3 function redundantly to
promote periderm differentiation in zebrafish.
Figure 3. Knockdown of grhl family members results in loss of periderm
markers. (a, b) Animal-pole view of 8 hours post fertilization (h.p.f.) embryos
injected mosaically with (a) biotinylated dextran mixed with lacZ or (b)
dnXgrhl1 messenger RNA. Embryos were fixed at shield stage and processed
to reveal krt4 expression (purple) and biotin (brown). Periderm cells inheriting
lacZ (brown nuclei) express krt4 variably, like periderm cells in uninjected
embryos, whereas those inheriting dnXGrhl1 (brown nuclei) lack krt4. (c–j)
Embryos injected with control morpholino oligonucleotide (MO) (c, e, g, i), or
grhl1 and grhl3 MOs (d, f, h, j), fixed at 8 h.p.f., and processed to reveal
expression of the indicated gene, or allowed to develop until 10 h.p.f. (i–j), at
which time control MO-injected embryos have normal morphology (i), and
grhl1/grhl3 MO-injected embryos are ruptured (j). Bars¼ (a) 50 mm; (a inset)
10mm; (c) 100 mm; (i) 100mm.
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Forced expression of grhl3 partially restores epiboly in dnIrf6-
injected embryos
During epiboly, blastomeres in control embryos migrate
toward the vegetal pole, producing doming of the yolk
toward the animal pole (Figure 4g and h). In the large
majority of embyros injected with dnIrf6 messenger RNA
(mRNA) and subsequently injected with a control mRNA (i.e.,
lacZ), these movements do not appear to occur (Figure 4h),
and virtually all have ruptured through the animal pole by the
time control embryos reach 6.5 h.p.f. (Figure 4e; 94%,
n¼114 injected embryos). By contrast, in the majority of
dnIrf6-injected embryos that are subsequently injected with
grhl3 mRNA, blastomeres move toward the vegetal pole, the
yolk undergoes doming, and embryos are still alive at
6.5 h.p.f. (Figure 4f and i; 70%, n¼ 119). Moreover, they
express the periderm markers claudinE, capn9, and ovol1 at
higher levels, as demonstrated by qRT-PCR analysis (Figure
4j) and confirmed by in situ hybridization for capn9 (Figure
4k–m). Most such embryos, nonetheless, ultimately rupture
by the time control embryos reach 7.5 h.p.f. (81%, n¼119).
Thus, grhl3 mRNA improved survival and morphogenesis
during epiboly of dnIrf6-injected embryos.
We also tested the ability of Grhl3 to reverse the effects of
MO-mediated knockdown of the irf6 mRNA in frog embryos.
Using the oocyte-transfer method to inhibit maternal irf6, we
confirmed the earlier report (Sabel et al., 2009) of a strong
reduction of the superficial epithelium marker Xk81a1 and
upregulation of the deep cell marker sox11 (Figure 4n). In
embryos that were additionally injected with the Xenopus
grhl3 mRNA, xk81a1 levels were significantly closer to
those in control embryos (Figure 4n). Thus, Irf6-mediated
activation of grhl3 expression appears to be a critical
component in the periderm gene regulatory network in fish
and frogs.
Expression of Grhl3 in murine Irf6-deficient embryos
We harvested epidermis from mouse embryos that expressed
wild-type and/or a null allele of Irf6 (i.e., homozygous
control, heterozgous mutant, or homozygous mutant) at
E14.5 and E17.5, and measured Grhl3 levels by qRT-PCR
analysis. In homozygous mutants, Grhl3 was reduced at
E14.5 but elevated at E17.5 with respect to the levels in
siblings (wild-type or heterozygous mutant; Figure 5a). The
elevation at the later time point is consistent with the
observation that epidermal stratification is abnormal (the
basal and spinous layers are expanded and exhibit inap-
propriate gene expression, and the granulosum and cornified
layers are absent; Ingraham et al., 2006; Richardson et al.,
2006). To determine the reason for the reduction in Grhl3
expression at E14.5, we evaluated anti-Grhl3 immunoreac-
tivity in coronal head sections from homozgyous Irf6 mutants
and their siblings at E14.5. In the sibling embryos, nuclear
Grhl3 immunoreactivity was detected in all layers of the
epidermis, with expression highest in periderm cell nuclei
(Figure 5b). In Irf6 mutants, Grhl3 immunoreactivity was
generally lower and non-nuclear, and the characteristic
periderm expression was absent (Figure 5c). Similar changes
in the gene expression pattern were observed in the oral
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Figure 4. Injection of Grainyhead-like 3 (grhl3) restores periderm markers in
dominant-negative variant of IFN regulatory factor 6 (dnIrf6)-injected embryos.
(a–i) Images of live (a–f) and 40-6-diamidino-2-phenylindole-stained sections
of (g–i) embryos injected with the indicated RNA. Insets, magnified images of
the boxed area. (g–i) The doming of the yolk apparent in lacz-injected
embyros (g) is lost in dnIrf6-injected embryos (h) and partially restored in
dnIrf6- and grhl3-injected embryos (i). (j) Quantitative reverse transcription PCR
(qRT-PCR) analysis of messenger RNA (mRNA) levels. capn9, P¼ 0.03, cldnE,
P¼0.003, ovol1, P¼ 0.048. (k–m) 5-Hours post fertilization (h.p.f.) embryos
processed for capn9 expression. (n) qRT-PCR analysis of levels of the periderm
marker xk81a1, and the deep blastomere marker sox11, in Xenopus embryos
derived from oocytes injected with control morpholino oligonucleotide (MO) or
irf6 MO and injected as zygotes with the XGrhl3 mRNA, as indicated. By
analysis of variance, xk81a1, Po0.0002, sox11, Po0.03. Error bars, standard
deviation. Bars¼ (a) 200mm; (g) 100mm; (k) 100mm.
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epithelium (Figure 5d and e). Together, these findings suggest
that Irf6 directly activates Grhl3 expression in the periderm
and oral epithelium in mice, and that in keratinocytes Irf6
contributes to the activation of Grhl3 expression but is not
essential for it.
Finally, we generated mutants doubly heterozygous for
Irf6 and Grhl3. In newborn Irf6gt/þ ; Grhl3del/þ pups, we
detected neither gross morphological defects in the face, ears,
limbs, or oral cavity nor obvious histological defects in skin
or oral epithelium (n¼6; not shown). Thus, if Irf6 and Grhl3
function in the same pathway during formation of the
permeability barrier, the dosage of neither gene is limiting
in double heterozygotes.
DISCUSSION
Irf6 and the periderm gene regulatory network
Here we have conducted profiling experiments that have
shed light on the role of Irf6 in zebrafish periderm
development. We used conservative criteria in identifying
genes in the periderm-enriched and dnIrf6-inhibited profiles,
and probes for some of the genes that are important for
epithelial development, including grhl3 itself, were not
represented on the microarray we deployed. Nonetheless,
the periderm-enriched profile includes at least 70 genes
encoding transcription factors, all of which are candidate
participants in the periderm transcriptional gene regulatory
network. Those that are also present in the dnIrf6-inhibited
profile include grhl1, tfap2c, klf2b, and c/ebp beta. Each of
these genes or a homolog has previously been implicated in
epithelial development. Notably, many of the regulatory
genes in the periderm profile are not in the dnIrf6-sensitive
profile, and these could play roles upstream of, or parallel to,
Irf6 during epithelial development. Candidates for regulatory
proteins acting upstream of Irf6 include TFAP2A (Rahimov
et al., 2008), aPKC (Chalmers et al., 2003), Ikk1 (Fukazawa
et al., 2010), and p63 (Moretti et al., 2010; Thomason et al.,
2010). Thus, our work has helped to place Irf6 within the
gene regulatory network that governs differentiation of the
zebrafish periderm, a tissue that serves as a model for other
simple squamous epithelia, including mammalian oral
periderm.
Grhl3 appears to be a direct effector of Irf6 in the periderm
Our results suggest that Irf6 directly regulates grhl3 expres-
sion and that in some tissues it may do so in conjunction with
other Irf family members. Specifically, we show that Grhl3
expression is strongly downregulated in the periderm of
zebrafish embryos injected with dnIrf6, consistent with
previous findings from Xenopus embryos derived from
oocytes injected with irf6 MO (Sabel et al., 2009), Irf6
mutant mouse embryos (Ingraham et al., 2006; Richardson
et al., 2006, 2009), and human keratinocytes transfected with
an small hairpin RNA targeting human IRF6 (Botti et al.,
2011). Moreover, we have identified two conserved noncod-
ing elements close to GRHL3—one known to be bound by
IRF6 in keratinocytes, and another strongly conserved Irf6
consensus binding site—both of which have zebrafish
periderm enhancer activity. We have also found that Grhl3
expression is not completely dependent on Irf6 in all
tissues—for instance, in mouse keratinoctyes; it is possible
that in such contexts Irf6 homologs cooperate with Irf6 to
regulate target gene expression. We note that the periderm-
enriched profile includes two irf6 homologs (namely, irf4a
and irf11). The presence of these genes, together with
maternally encoded irf6, may explain why dnIrf6 effectively
reduces grhl3 expression upon injection into zebrafish eggs,
whereas the irf6 MO does not (our unpublished finding). We
also note that a chromatin precipitation with next generation
sequencing (ChIP/SEQ) experiment found that IRF4 binds
intron-15 of GRHL3 in a lymphoblast cell line (ENCODE
project, Rick Myers laboratory, HudsonAlpha Institute). In
summary, the available genetic and biochemical evidence
indicates that Irf6, possibly in conjunction with its homologs,
directly activates grhl3 expression in epithelial structures.
Clinical and evolutionary implications
Because Grhl3 appears to act in concert with Irf6 in the oral
periderm gene regulatory network, mutations in GRHL3, and
in genes encoding other members of this network, are
candidates that contribute risk for CL/P. Although mutations
E14.5
E1
4.
5 
sk
in
O
ra
l e
pi
th
.
7
6
5
4
3
2
1
0
E17.5
Irf6 mutant
Periderm
50 μm
Irf6 mutant
Irf6 mutant
Irf6 mutant
Sibling
Sibling
Sibling
Grhl3
Sibling
m
G
rh
l3
re
la
tiv
e
 le
ve
ls
Figure 5. Expression of Grhl3 in Irf6-deficient mice. (a) Quantitative reverse
transcription PCR analysis of Grhl3 levels in epidermis harvested at the
indicated stage: E14.5, two replicates; E17.5, three replicates; Po0.03. (b–e)
Anti-Grhl3 immunofluorescence on the indicated tissue at the indicated
stages. In the epidermis of sibling control embryos (b), Grhl3
immunoreactivity (IR) is prominent in all epidermal and peridermal nuclei. In
mutant embyros (c), Grhl3 IR is diffuse, non-nuclear, and weak or
undetectable in the periderm. In the oral epithelium (epith.) of control siblings
(d), Grhl3 IR is strong in all nuclei and strongest in the oral periderm. In
mutant embryos (e), Grhl3 IR is highly reduced. (b) Bar¼50 mm.
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in IRF6 have been estimated to confer 12% of the inherited
risk for nonsyndromic CL/P (Zucchero et al., 2004), the
majority of such a risk has not been ascribed to any gene
(Yuan et al., 2011). In mice, Irf6 is necessary for differentia-
tion of the oral epithelium, particularly that of the oral
periderm (Richardson et al., 2009). Grhl3 is expressed in the
zebrafish oral epithelium (our unpublished findings) and in
mouse embryos (Auden et al., 2006). Furthermore, as
recently reported, mouse Grhl2 mutants exhibit orofacial
clefts (Pyrgaki et al., 2011). Although our macroscopic
analyses of Irf6gt/þ ;Grhl3del/þ double-heterozygous mice at
birth did not detect gross anomalies in skin development, it
will be important to assess embryos for the presence of oral
adhesions. Importantly, the absence of a phenotype in double
heterozygotes is not strong evidence against two genes acting
in the same pathway. Indeed, the related defects in barrier
function in Grhl3 and Irf6 mutants suggest that the two genes
promote skin differentiation through the same pathway (Ting
et al., 2005; Ingraham et al., 2006; Richardson et al., 2006).
In addition, the ability of Grhl3 to rescue the expression of
periderm markers in dnIrf6-injected embryos, as shown here,
is strong evidence that they act in the pathway that promotes
periderm differentiation. The data presented here motivate an
assessment of overtransmission of specific alleles of GRHL3
(or other GRHL family members) in patients with nonsyn-
dromic CL/P, and of mutations in GRHL3 in patients with
syndromic forms of CL/P. In this context, it is intriguing that
three linkage studies have detected a risk locus at 1p36,
where GRHL3 resides (Prescott et al., 2000; Martinelli et al.,
2001; Moreno et al., 2004), and Van der Woude Syndrome 2
(VWS2), which includes orofacial clefting, maps to an
interval that contains GRHL3 (Koillinen et al., 2001).
Finally, our data lead us to speculate how the role of IRF6
in epithelial development evolved. The IRFs are ancient,
having arisen alongside multicellularity in animals (Nehyba
et al., 2009); the GRHL family is also ancient, having arisen
before the split of arthropods and chordates (Ting et al.,
2005). Most members of the IRF family regulate the
expression of genes that encode IFNs and proteins that
promote the differentiation of dendritic cells (Gabriele and
Ozato, 2007). Activation by IRF6 of GRHL3, which encodes
a regulator of epithelial integrity, does not appear to fit this
pattern, suggesting this regulatory interaction is an evolu-
tionary novelty. However, given that the most important
aspect of innate immunity is the epidermal permeability
barrier, a unifying theme of IRF targets is their involvement in
innate immunity. It is plausible that activation by IRF6 of
GRHL3 reflects an ancient interaction that evolved as one
feature of the innate immune response.
MATERIALS AND METHODS
Dissociation of zebrafish embryos, FACS, and RNA preparation
For production of the periderm-enriched profile, about 200
heterozygous transgenic tg(krt4:gfp) (Gong et al., 2002) embryos
were reared to 11 h.p.f., pestle homogenized, and dissociated with
phosphate-buffered saline containing 0.25% trypsin and 1mM EDTA
(Gibco, # 25200, Invitrogen, Carlsbad, CA) for 30minutes at 33 1C.
Cells were resuspended in phosphate-buffered saline plus 3% fetal
bovine serum and sorted on a FACS DiVa (Becton Dickinson,
Franklin Lakes, NJ), directly into a buffer containing guanidinium
thiocyanate for subsequent RNA isolation using the RNEasy Plus
Mini Kit (i.e., Buffer RLT, QIAGEN, Valencia, CA). RNA was
subjected to two rounds of amplification using the Message Amp II
aRNA Amplification Kit (Invitrogen). For production of the dnIrf6-
inhibited profile, embryos were injected with dnIrf6 or the lacZ
mRNA, raised to 6 h.p.f., and homogenized. RNA was extracted
from the dnIrf6- or control RNA–injected embryos as described
above, without an amplification step. RNA was pooled from a total
of approximately 100 embryos of each type; both types were
generated on two separate injection days.
Complementary DNA (cDNA) preparation and probe
hybridization
For production of the periderm-enriched profile, we synthesized and
labeled cDNA once, and hybridized six arrays each with the two
classes of probes, using cDNA microarrays in the 12-plex format
(Design number 090505_Zv7_EXPR_HX12, Roche NimbleGen,
Madison, WI). The periderm-enriched profile was thus generated
from a single biological replicate (of about 200 animals) and six
technical replicates. On the basis of technical replicates, the false
discovery rate-adjusted P-values for all genes in the periderm
profile were lower than 108. For the dnIrf6-inhibited profile, three
cDNA synthesis reactions were performed on the pooled RNA,
probes were generated from each cDNA preparation, and three
arrays (technical replicates) were hybridized with each probe
reaction. Differentially expressed genes were selected on the basis
of an false discovery rate-adjusted P-value cutoff of 0.05, and a fold-
change cutoff of 1.7. Because the periderm-enriched and dnIrf6-
inhibited profiles were created from embryos at different ages, the
periderm-enriched profile was filtered of all genes whose expression
at 6 h.p.f. in lacz-injected embryos was not above threshold (defined
in Supplementary Methods online) before overlap between the two
profiles was evaluated.
Reporter experiments
Construction of reporters to test enhancer function of the human and
mouse genomic elements is described in Supplementary Methods
online. At 48 h.p.f., 20% (20 of 97 injected embryos) of zebrafish
embryos injected with hGRHL3_peak2:gfp exhibited patches of 10
or more GFP-positive periderm cells, whereas none of those injected
with hGRHL3_peak1:gfp (80 injected embryos) or with the pGW_
cfosEGFP vector lacking an insert (43 injected embryos) did so.
For both the wild-type Irf6RE and the DIrf6RE variant, embryos
were injected with 5 nl of plasmid (0.05 mgml1) plus tol2 mRNA
(25 ng ml1) at the single-cell stage. Embryos at shield stage (6 h.p.f.)
were scored, using a Leica epifluorescence compound microscope
(Leica, Wetzlar, Germany), for GFP expression in greater than 10
contiguous periderm cells and persisting until 48 h.p.f. (mGrhl3in-
tron15:gfp, 40%, n¼ 79 embryos; 0%, intron15 DIrf6RE, n¼ 91
embryos). A 5mm step z-stack was taken, and the ‘‘auto-blend’’
feature of Photoshop CS3 was used to merge it into a single image
(Figure 2f). We raised injected founders and identified two that
transmitted GFP in the F1 generation. One exhibited high-level GFP
expression throughout the periderm, like the transient transgenic
embryos (shown in Figure 2h), whereas the other exhibited GFP
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expression in facial periderm, in hatching gland cells, and in
unidentified oral structures.
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